© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Researchers recommend screening for fatty liver disease within this population.
Targeting a protein called cyclin D1 may be beneficial in cancer treatment in the setting of obesity and Type 2 diabetes.
Obesity increased the risk of liver disease to a smaller extent, according to a meta-analysis study.
People with cancer, heart disease and diabetes are at increased risk for serious illness from COVID-19.
This benefit was independent of weight control among the animals.
In a mouse study, they found a pair of proteins that are instrumental in the development of diabetes, one of which helps regulate fibrosis.
Non-alcoholic steatohepatitis is an advanced form of non-alcoholic fatty liver disease associated with type 2 diabetes.
The new, minimally invasive outpatient procedure targets a part of the small intestine that plays a key role in diabetes.
A look at the link between hepatitis C after treatment and type 2 diabetes.
Apple cider vinegar has been touted as a health elixir, but is it?
NAFLD appears to have a “bidirectional” course in patients with type 2 diabetes, according to new findings.
People with type 2 diabetes and hepatitis C virus (HCV) who cure the virus tend to improve their blood sugar levels.
A roundup of key findings from the Annual Meeting of the American Association for the Study of Liver Diseases in Washington, DC
This is according to a large study including a median three years of follow-up.
Could one of these chronic health conditions be raising the risk of the other?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.